0
Back To Top Jump Location
Sign In  | Cart
Journals | Topic Collections | CME | Guidelines | Subscribe
Left Shadow
Right Shadow
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Research |  May 21, 2013
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction: Results of the SELECT-ACS Trial
Jean-Claude Tardif, MD; Jean-François Tanguay, MD; Scott S. Wright, MD; et al.
J Am Coll Cardiol. 2013;61(20):2048-2055. doi:10.1016/j.jacc.2013.03.003.
Clinical Research |  May 21, 2013
Prognostic Interplay of Coronary Artery Calcification and Underlying Vascular Dysfunction in Patients With Suspected Coronary Artery Disease
Masanao Naya, MD, PhD; Venkatesh L. Murthy, MD, PhD; Courtney R. Foster, RT; et al.
J Am Coll Cardiol. 2013;61(20):2098-2106. doi:10.1016/j.jacc.2013.02.029.
INCLUDES: Supplemental Content
Clinical Research |  May 21, 2013
Patterns of Use and Comparative Effectiveness of Bleeding Avoidance Strategies in Men and Women Following Percutaneous Coronary Interventions: An Observational Study From the National Cardiovascular Data Registry
Stacie L. Daugherty, MD, MSPH; Lauren E. Thompson, MD; Sunghee Kim, PhD; et al.
J Am Coll Cardiol. 2013;61(20):2070-2078. doi:10.1016/j.jacc.2013.02.030.
INCLUDES: Supplemental Content
Clinical Research |  May 21, 2013
Relationship Between Voltage Map “Channels” and the Location of Critical Isthmus Sites in Patients With Post-Infarction Cardiomyopathy and Ventricular Tachycardia
Stavros E. Mountantonakis, MD; Robert E. Park; David S. Frankel, MD; et al.
J Am Coll Cardiol. 2013;61(20):2088-2095. doi:10.1016/j.jacc.2013.02.031.
Clinical Research |  May 21, 2013
Triple Antithrombotic Therapy With Prasugrel in the Stented Patient: Concern for More Bleeding⁎⁎ 
Paul A. Gurbel, MD; Udaya S. Tantry, PhD
J Am Coll Cardiol. 2013;61(20):2067-2069. doi:10.1016/j.jacc.2013.02.032.
Clinical Research |  May 21, 2013
Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
Nikolaus Sarafoff, MD; Amadea Martischnig, MD; Jill Wealer, MS; et al.
J Am Coll Cardiol. 2013;61(20):2060-2066. doi:10.1016/j.jacc.2013.02.036.
Clinical Research |  May 21, 2013
Channeling Post-Infarction Ventricular Tachycardia Ablation: “Electroanatomy” Versus Electrophysiology⁎⁎ 
Haris M. Haqqani, MBBS(Hons), PhD; Joseph B. Morton, MBBS, PhD; Jonathan M. Kalman, MBBS, PhD
J Am Coll Cardiol. 2013;61(20):2096-2097. doi:10.1016/j.jacc.2012.11.076.
Clinical Research |  May 14, 2013
Renoprotective Effect of Remote Ischemic Post-Conditioning by Intermittent Balloon Inflations in Patients Undergoing Percutaneous Coronary Intervention
Spyridon Deftereos, MD; Georgios Giannopoulos, MD; Vasileios Tzalamouras, MD; et al.
J Am Coll Cardiol. 2013;61(19):1949-1955. doi:10.1016/j.jacc.2013.02.023.
Clinical Research |  May 14, 2013
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
Jonathan P. Piccini, MD, MHS; Susanna R. Stevens, MS; Yuliya Lokhnygina, PhD; et al.
J Am Coll Cardiol. 2013;61(19):1998-2006. doi:10.1016/j.jacc.2013.02.025.
Clinical Research |  May 07, 2013
Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2–TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction-51)
Jessica L. Mega, MD, MPH; Eugene Braunwald, MD; Sabina A. Murphy, MPH; et al.
J Am Coll Cardiol. 2013;61(18):1853-1859. doi:10.1016/j.jacc.2013.01.066.
INCLUDES: Supplemental Content
Left Shadow
Right Shadow
logo © 2013 American College of Cardiology Foundation
Powered bySilverchair Information Systems